Latest News

June 02, 2011
The nation’s system of freeing some terminally ill prisoners on grounds of compassionate release is so riddled with medical flaws and procedural barriers that many potentially medically eligible inmates are dying behind bars, say UCSF researchers in a new study.
May 06, 2011
The ongoing controversy surrounding the safety of using TASER® electrical stun guns took a new turn today when a team of cardiologists at the University of California, San Francisco announced findings suggesting that much of the current TASER®-related safety research may be biased due to ties to the devices’ manufacturer, TASER International, Inc.
April 11, 2011
Scientists at UCSF have pinpointed a reason older adults have a harder time multitasking than younger adults: they have more difficulty switching between tasks at the level of brain networks.
March 28, 2011
Calculations by researchers at UCSF and the University of California, Berkeley estimate that the cancer risk associated with one type of airport security scanners is low based on the amount of radiation these devices emit, as long as they are operated and function correctly.
February 11, 2011
David Durenberger and Susan Bartlett Foote will outline a new look at the legal and political issues related to health care reform. Both are guest speakers at the UCSF Philip R. Lee Institute for Health Policy Studies seminar series on health reform.
January 18, 2011
Low blood levels of beta-amyloid 42, a protein-like substance, were associated with the risk of significant cognitive decline within nine years in a group of elders, in a study led by Kristine Yaffe, MD, chief of geriatric psychiatry at the San Francisco VA Medical Center.
December 16, 2010
Cystatin C, a blood marker of kidney function, proved significantly more accurate than the standard blood marker, creatinine, in predicting serious complications of kidney disease, in a study by researchers at the San Francisco VA Medical Center and UCSF.
December 13, 2010
UCSF researchers have identified an existing medication that restores key elements of the immune system that, when out of balance, lead to a steady decline in immunity and health as people age.
November 29, 2010
In a new UCSF study of more than 2 million mammogram screenings performed on nearly 700,000 women in the United States, scientists for the first time show a direct link between reduced hormone therapy and declines in ductal carcinoma in situ (DCIS) as well as invasive breast cancer.
November 04, 2010
Four UCSF scientists sent a letter last April to the President’s Office of Science and Technology Policy, expressing concern about the health risks of full body scanners being implemented at U.S. airports.

Pages